Eberconazole nitrate

Eberconazole nitrate is a dichlorinated imidazole derivative with antifungal activity. Eberconazole nitrate is more effective than Clotrimazole (HY-10882), Ketoconazole (HY-B0105), and Miconazole (HY-B0454) . Eberconazole nitrate has potential for the study of dermatophytosis[1][2].

Product Specifications

CAS Number

[130104-32-4]

UNSPSC

12352005

Hazard Statement

H302

Target

Fungal

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/eberconazole-nitrate.html

Purity

99.76

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

ClC1=C2C(C3=CC=CC=C3CCC2=CC(Cl)=C1)N4C=CN=C4.[O-][N+](O)=O

Molecular Formula

C18H15Cl2N3O3

Molecular Weight

392.24

Precautions

H302

References & Citations

[1]Fernández-Torres B, et al. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J Clin Microbiol. 2003;41 (11) :5209-5211. |[2]Moodahadu L S, et al. Preclinical pharmacological profile of Eberconazole: A review and update[J]. Muller Journal of Medical Sciences and Research, 2014, 5 (2) : 159-165.